Results 1 to 10 of about 1,714,381 (280)

Rheumatoid arthritis [PDF]

The Lancet, 2016
Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability. Early diagnosis is key to optimal therapeutic success, particularly in patients with well-characterised risk factors for poor ...
Aletaha, Daniel, McInnes, Iain B., Smolen, Josef S.   +2 more
core   +2 more sources

Distinct fibroblast subsets drive inflammation and damage in arthritis

Nature, 2019
The identification of lymphocyte subsets with non-overlapping effector functions has been pivotal to the development of targeted therapies in immune-mediated inflammatory diseases (IMIDs)1,2. However, it remains unclear whether fibroblast subclasses with
Adam P Croft, Joana Campos, Kathrin Jansen   +2 more
exaly   +2 more sources

Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study

Arthritis Research & Therapy, 2022
Background The use of tramadol among osteoarthritis (OA) patients has been increasing rapidly around the world, but population-based studies on its safety profile among OA patients are scarce.
Lingyi Li, Shelby Marozoff, Na Lu, Hui Xie, Jacek A. Kopec, Jolanda Cibere, John M. Esdaile, J. Antonio Aviña-Zubieta   +7 more
doaj   +1 more source

A Holistic Approach on Smart Garment for Patients with Juvenile Idiopathic Arthritis [PDF]

10.3390/engproc2023059083;2023, 2023
Juvenile Idiopathic Arthritis (JIA) is a widespread and chronic condition that affects children and adolescents worldwide. The person suffering from JIA is characterized by chronic joint inflammation leading to pain, swelling, stiffness, and limited body movements. Individuals suffering from JIA require ongoing treatment for their lifetime.
arxiv   +1 more source

The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018

Arthritis Research & Therapy, 2023
Purpose We aimed to explore the relationship between the systemic immune-inflammation index (SII) and rheumatoid arthritis (RA) using NHANES from 1999 to 2018. Methods We collected data from the NHANES database from 1999 to 2018.
Bo Liu, Jie Wang, Yan-yan Li, Kang Li, Qiang Zhang   +4 more
semanticscholar   +1 more source

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

Arthritis care & research, 2020
To develop an evidence‐based guideline for the comprehensive management of osteoarthritis (OA) as a collaboration between the American College of Rheumatology (ACR) and the Arthritis Foundation, updating the 2012 ACR recommendations for the management of
S. Kolasinski, T. Neogi, M. Hochberg, C. Oatis, G. Guyatt, J. Block, L. Callahan, Cindy Copenhaver, Carole V Dodge, D. Felson, Kathleen Gellar, W. Harvey, G. Hawker, Edward Herzig, C. Kwoh, A. Nelson, J. Samuels, C. Scanzello, D. White, B. Wise, R. Altman, D. DiRenzo, J. Fontanarosa, Gina Giradi, Mariko L. Ishimori, D. Misra, A. A. Shah, A. Shmagel, L. Thoma, Marat Turgunbaev, Amy S. Turner, J. Reston   +31 more
semanticscholar   +1 more source

Bibliometric and visualization analysis of stem cell therapy for meniscal regeneration from 2012 to 2022

Frontiers in Bioengineering and Biotechnology, 2023
Background: Meniscus injuries, a common joint disease caused by long-term wear, trauma and inflammation, usually cause chronic dysfunction and pain in the joint.
Zhen Yang, Zhen Yang, Zejun Fan, Du Wang, Du Wang, Hui Li, Hui Li, Zihao He, Zihao He, Dan Xing, Dan Xing, Jianhao Lin, Jianhao Lin   +12 more
doaj   +1 more source

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis & Rheumatology, 2021
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis.
L. Fraenkel, J. Bathon, B. England, E. St. Clair, T. Arayssi, Kristine Carandang, K. Deane, M. Genovese, K. Huston, G. Kerr, J. Kremer, Mary C. Nakamura, L. Russell, Jasvinder A. Singh, Benjamin J. Smith, J. Sparks, S. Venkatachalam, M. Weinblatt, Mounir Al-Gibbawi, J. Baker, K. Barbour, J. Barton, L. Cappelli, Fatimah Chamseddine, M. George, S. Johnson, Lara A. Kahale, Basil S. Karam, A. Khamis, I. Navarro-Millán, R. Mirza, P. Schwab, Namrata Singh, Marat Turgunbaev, Amy S. Turner, Sally Yaacoub, E. Akl   +36 more
semanticscholar   +1 more source

Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID‐19 Outcomes: A Population‐Based Cohort Study

ACR Open Rheumatology, 2023
Objective We estimated the association between immunosuppressive and immunomodulatory agent (IIA) exposure and severe COVID‐19 outcomes in a population‐based cohort study.
Shelby Marozoff, Jeremiah Tan, Na Lu, Ayesha Kirmani, Jonathan M. Loree, Hui Xie, Diane Lacaille, Jacek A. Kopec, John M. Esdaile, Bonnie Corradetti, Peter Malone, Cheryl L. Koehn, Philippa Mennell, Alison M. Hoens, J. Antonio Aviña‐Zubieta   +14 more
doaj   +1 more source

Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study

BMJ Open, 2022
Objectives To assess the risk of severe COVID-19 outcomes in patients with autoimmune rheumatic diseases (ARDs) and transplant recipients compared with matched general population comparators.Design Population-based matched cohort study using ...
John Esdaile, Jacek A Kopec, Diane Lacaille, Na Lu, J Antonio Aviña-Zubieta, Hui Xie, Shelby Marozoff, Jonathan M Loree   +7 more
doaj   +1 more source